| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 | OM Outset Medical, Inc. | Brottem John L.84 | General Counsel | Sell | 224 | $4.27 | $956.48 | -0.5% | -5.5% | - | |
| Jan 7, 2026 | OM Outset Medical, Inc. | Nash Marc83 | EVP Operations R&D &Service | Sell | 108 | $4.27 | $461.16 | -0.2% | -5.5% | - | |
| Jan 7, 2026 | RMD Resmed Inc | Farrell Michael J.62 | Chairman And CEO | Sell | 4,991 | $248.46 | $1,240,065.36 | -1.1% | -8.9% | - | |
| Jan 7, 2026 | INCY Incyte Corp | Issa Mohamed Khairie | EVP, Head Of Us Oncology | Sell | 10,856 | $109.07 | $1,184,063.92 | -14.1% | -15.3% | - | |
| Jan 7, 2026 | LUCY Innovative Eyewear Inc | Galkin Vladimir68 | 10% Owner | Buy | 647,505 | $1.79 | $1,155,953.95 | -16,188% | -37.9% | - | |
| Jan 6, 2026 | PEN Penumbra Inc | Grewal Harpreet60 | Director | Sell | 186 | $312.64 | $58,151.04 | -2.2% | +4.1% | - | |
| Jan 6, 2026 | EW Edwards Lifesciences Corp | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sell | 11,340 | $85.66 | $971,429.16 | -13.5% | -5.4% | - | |
| Jan 6, 2026 | BLFS Biolife Solutions Inc | Aebersold Sarah61 | Chief Human Resources Officer | Sell | 241 | $25.59 | $6,167.19 | -0.3% | -26.9% | - | |
| Jan 6, 2026 | BLFS Biolife Solutions Inc | Berard Todd68 | Chief Marketing Officer | Sell | 344 | $25.59 | $8,802.96 | -0.3% | -26.9% | - | |
| Jan 6, 2026 | WRBY Warby Parker Inc. | Blumenthal Neil Harris66 | Co-chief Executive Officer | Sell | 150,000 | $25.09 | $3,763,500.00 | -36.5% | -18.9% | - | |
| Jan 6, 2026 | EKSO Ekso Bionics Holdings, Inc. | Jones Jason C64 | Chief Operating Officer | Sell | 1,320 | $9.25 | $12,210.00 | -4.9% | +2.3% | - | |
| Jan 6, 2026 | SGHT Sight Sciences, Inc. | Taylor Brenton74 | EVP, Operations &R&D | Sell | 619 | $7.48 | $4,630.12 | -0.4% | -52.5% | - | |
| Jan 6, 2026 | BLFS Biolife Solutions Inc | Wichterman Troy61 | Chief Financial Officer | Sell | 990 | $25.59 | $25,334.10 | -0.7% | -26.9% | - | |
| Jan 6, 2026 | BLFS Biolife Solutions Inc | Foster Karen A.68 | Chief Quality And Operations | Sell | 335 | $25.59 | $8,572.65 | -0.2% | -26.9% | - | |
| Jan 6, 2026 | MMSI Merit Medical Systems Inc | Peterson Neil W.51 | Chief Operating Officer | Sell | 5,000 | $90.00 | $450,000.00 | -15.0% | -27.1% | - | |
| Jan 6, 2026 | BLFS Biolife Solutions Inc | Mathew Aby J.69 | EVP &Chief Scientific Officer | Sell | 405 | $25.59 | $10,363.95 | -0.1% | -26.9% | - | |
| Jan 6, 2026 | BBNX Beta Bionics, Inc. | Mensinger Mike | Chief Product Officer | Sell | 2,200 | $30.10 | $66,221.10 | -2.7% | -68.3% | - | |
| Jan 6, 2026 | SGHT Sight Sciences, Inc. | Hayden Jeremy B.63 | Chief Legal Officer | Sell | 11,170 | $7.77 | $86,742.50 | -2.2% | -52.5% | - | |
| Jan 6, 2026 | SGHT Sight Sciences, Inc. | Bauerlein Alison73 | Chief Operating Officer | Sell | 20,543 | $7.66 | $157,366.28 | -1.7% | -52.5% | - | |
| Jan 6, 2026 | MOVE Movano Inc. | Cogan Jeremy | CFO | Sell | 10,097 | $7.89 | $79,675.05 | -14.8% | -2.1% | - | |
| Jan 6, 2026 | SGHT Sight Sciences, Inc. | Rodberg James62 | Chief Financial Officer | Sell | 4,999 | $7.78 | $38,890.22 | -1.6% | -52.5% | - | |
| Jan 6, 2026 | SGHT Sight Sciences, Inc. | Badawi Paul62 | President And CEO | Sell | 37,226 | $7.45 | $277,182.68 | -0.3% | -52.5% | - | |
| Jan 6, 2026 | WRBY Warby Parker Inc. | Gilboa David Abraham62 | Co-chief Executive Officer | Sell | 75,000 | $23.68 | $1,776,000.00 | -50.2% | -18.9% | - | |
| Jan 6, 2026 | SGHT Sight Sciences, Inc. | Badawi David59 | Chief Technology Officer | Sell | 9,660 | $7.57 | $73,148.44 | -0.2% | -52.5% | - | |
| Jan 5, 2026 | BFLY Butterfly Network, Inc. | Ku Victor | Chief Technology Officer | Sell | 35,968 | $3.82 | $137,397.76 | -4.2% | +6.7% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.